
New sensor sniffs out pneumonia on a patient’s breath
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.

The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells.

From cobblers to smoothies, dark sweet cherries show up in plenty of recipes, and scientists say the crimson-colored fruit may contain compounds that could help fight an aggressive type of breast cancer.

According to multiple reports, the Chinese medical device regulatory body granted Neuracle the country’s first approval for a brain-computer interface (BCI).

Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic reticulum serves as a transport hub and lysosomes help with waste disposal.

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer’s disease.

Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence (IPV) using information from their electronic medical records (EMRs).

Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient’s lungs, legs, feet, and other parts of the body. The condition is chronic and incurable, often leading to arrhythmias or sudden cardiac arrest. For many centuries, bloodletting and leeches were the treatment of choice, famously practiced by barber surgeons in Europe, during a time when physicians rarely operated on patients.

Johnson & Johnson (NYSE: JNJ)+ announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.

Procept BioRobotics (Nasdaq:PRCT) today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.